Sequence alignments and bioinformatics analyses performed in our lab suggested that miR-3928 can theoretically target many important oncogenes in GBM, including MDM2, CD44, DDX3X, HMGA2, CCND1, BRAF, ATOH8, and BMI1. Here, MDM2 is linked to glioblastoma.